JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 34 No. 6 889-894
© 1993 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Günalp, B.
Right arrow Articles by Öztürk, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Günalp, B.
Right arrow Articles by Öztürk, E.

Value of Dobutamine Technetium-99m-Sestamibi SPECT and Echocardiography in the Detection of Coronary Artery Disease Compared with Coronary Angiography

Bengül Günalp, Barbaros Dokumaci, Cihangir Uyan, Erkan Vardareli, Ersoy Isik, Hikmet Bayhan, Mehmet Özgüven and Emel Öztürk

Departments of Nuclear Medicine and Cardiology, Gülhane Military Medical Academy and Faculty, Ankara, Turkey

Correspondence: For correspondence or reprints contact: Bengül Günalp, MD, Gülhane Askeri Tip Akademisi, Nükleer Tip Anabilim Dali, 06018 Etlik Ankara, Turkey.

ABSTRACT

The value of dobutamine echocardiography and 99mTc-sestamibi SPECT imaging was evaluated as a noninvasive diagnostic method for assessing coronary artery disease (CAD).Twenty-seven patients who underwent coronary angiography were submitted to two separate injections of 99mTc-sestamibi, one under control conditions and the other after reaching a peak dobutamine infusion rate. Simultaneous ECG and echocardiographic monitoring was also performed during stepwise dobutamine infusion. Whereas the overall sensitivity and specificity of dobutamine sestamibi SPECT imaging were 94% and 88%, these values for dobutamine ECG and echocardiography were 61%, 55% and 84%, 88%, respectively. When dobutamine echocardiography and 99mTc-sestamibi SPECT imaging were evaluated together, the diagnostic accuracy reaches almost 100%. Dobutamine echocardiography is of value in determining ischemic threshold earlier than clinical symptoms and allows simultaneous evaluation of ventricular performance and contractile function associated with perfusion abnormalities on 99mTc-sestamibi SPECT imaging. Our experience shows that 99mTc-sestamibi SPECT imaging, when combined with dobutamine echocardiography, is a safe, practical, well tolerated method with high diagnostic accuracy for the evaluation of CAD.




This article has been cited by other articles:


Home page
Eur J EchocardiogrHome page
R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, and on behalf of the European Association of Echocardi
Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC)
Eur J Echocardiogr, July 1, 2008; 9(4): 415 - 437.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
R. Sharma and S. J Brecker
Dobutamine stress echocardiography in diabetes
The British Journal of Diabetes & Vascular Disease, January 1, 2005; 5(1): 42 - 46.
[Abstract] [PDF]


Home page
HeartHome page
C Y Loong and C Anagnostopoulos
Diagnosis of coronary artery disease by radionuclide myocardial perfusion imaging
Heart, August 1, 2004; 90(suppl_5): v2 - v9.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. D. Cheitlin, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, J. L. Davis, P. S. Douglas, D. P. Faxon, L. D. Gillam, T. R. Kimball, et al.
ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: summary article: a report of the American college of cardiology/American heart association task force on practice guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography)
J. Am. Coll. Cardiol., September 3, 2003; 42(5): 954 - 970.
[Full Text] [PDF]


Home page
CirculationHome page
M. D. Cheitlin, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, J. L. Davis, P. S. Douglas, D. P. Faxon, L. D. Gillam, T. R. Kimball, et al.
ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography)
Circulation, September 2, 2003; 108(9): 1146 - 1162.
[Full Text] [PDF]


Home page
Eur Heart JHome page
A.F.L Schinkel, J.J Bax, M.L Geleijnse, E Boersma, A Elhendy, J.R.T.C Roelandt, and D Poldermans
Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography?
Eur. Heart J., May 1, 2003; 24(9): 789 - 800.
[Full Text] [PDF]


Home page
JNMHome page
A. Elhendy, J. J. Bax, and D. Poldermans
Dobutamine Stress Myocardial Perfusion Imaging in Coronary Artery Disease
J. Nucl. Med., December 1, 2002; 43(12): 1634 - 1646.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P Lancellotti, T Benoit, P Rigo, and L A Pierard
Dobutamine stress echocardiography versus quantitative technetium-99m sestamibi SPECT for detecting residual stenosis and multivessel disease after myocardial infarction
Heart, November 1, 2001; 86(5): 510 - 515.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. L. Geleijnse, A. Elhendy, P. M. Fioretti, and J. R. T. C. Roelandt
Dobutamine stress myocardial perfusion imaging
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2017 - 2027.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J A S. Román, I Vilacosta, J A Castillo, M J Rollán, M Hernández, V Peral, I Garcimartín, M d. M. de la Torre, and F Fernández-Avilés
Selection of the optimal stress test for the diagnosis of coronary artery disease
Heart, October 1, 1998; 80(4): 370 - 376.
[Abstract] [Full Text]


Home page
CirculationHome page
D. A. Calnon, D. K. Glover, G. A. Beller, G. Vanzetto, W. H. Smith, D. D. Watson, and M. Ruiz
Effects of Dobutamine Stress on Myocardial Blood Flow, 99mTc Sestamibi Uptake, and Systolic Wall Thickening in the Presence of Coronary Artery Stenoses : Implications for Dobutamine Stress Testing
Circulation, October 7, 1997; 96(7): 2353 - 2360.
[Abstract] [Full Text]


Home page
CirculationHome page
M. L. Geleijnse, A. Elhendy, R. T. van Domburg, J. H. Cornel, R. Rambaldi, A. Salustri, A. E. M. Reijs, J. R. T. C. Roelandt, and P. M. Fioretti
Cardiac Imaging for Risk Stratification With Dobutamine-Atropine Stress Testing in Patients With Chest Pain : Echocardiography, Perfusion Scintigraphy, or Both?
Circulation, July 1, 1997; 96(1): 137 - 147.
[Abstract] [Full Text]


Home page
CirculationHome page
M. D. Cheitlin, J. S. Alpert, W. F. Armstrong, G. P. Aurigemma, G. A. Beller, F. Z. Bierman, T. W. Davidson, J. L. Davis, P. S. Douglas, L. D. Gillam, et al.
ACC/AHA Guidelines for the Clinical Application of Echocardiography : A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Clinical Application of Echocardiography) Developed in Collaboration With the American Society of Echocardiography
Circulation, March 18, 1997; 95(6): 1686 - 1744.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1993 by the Society of Nuclear Medicine.